Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

7.905 -0.165 (-2.04%)
Streaming Delayed Price Updated: 12:17 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >
News headline image
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
From Bioventus, Inc.
Via GlobeNewswire
News headline image
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Bioventus Names Robert Claypoole as President and Chief Executive Officer
Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth 
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the Cantor Global Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Completes Divestiture of its Wound Business
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Announces Divestiture of its Wound Business
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Inc. (NASDAQ:BVS) Long Term Investor Notice: Investigation of Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 04/25/2023 -- An investigation was announced for long-term investors in shares of Bioventus Inc. (NASDAQ:BVS) concerning potential breaches of fiduciary duties by certain... 
Via SBWire
News headline image
Bioventus Announces CEO Leadership Change
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Bioventus Inc. (BVS) Investors of Class Action and Last Few Hours to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
BVS DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important March 13 Deadline in Securities Class Action - BVS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
BIOVENTUS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bioventus Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
BVS MONDAY DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Bioventus Inc. Investors to Secure Counsel Before Important March 13 Deadline in Securities Class Action - BVS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Southwest Airlines, Y-mAbs, Bioventus, and ESS and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Bioventus Inc. (BVS) Investors and Encourages Investors to Contact the Firm Before March 13, 2023
From Kirby McInerney LLP
Via Business Wire
News headline image
BIOVENTUS INC. (NASDAQ: BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bioventus Inc. (NASDAQ: BVS)
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.